Main features of the Dutch DRG package of specialist medical care in 2019

13

Dec 2017

The Dutch Health Care Authority (NZa) has published the main features of the DBC package for specialist medical care in 2019 (RZ19a) with an explanation of the most important proposed changes in regulations, DBC structure, and tariffs.

The following types of care will be implemented in 2019:

  • Pediatric oncology: in 2019, NZa make will make it possible to record recurrence treatment for pediatric oncology.
  • Proton therapy: since January 1, 2019, proton therapy will be included in the product structure of the DBC system for hospital care.
  • Telemedicine: E-health can make health care better, more comfortable and probably cheaper. That is why the NZa wants to stimulate the use of e-health applications, and innovation/e-health development is part of its strategy. In the 2018 DBC package, NZa made it possible for remote consultations to be reimbursed. Reimbursement for telemedicine is proposed for 2019. Until 2019, telemedicine was a part of the outpatient clinic visit. However, telemedicine for monitoring patient is always accompanied by (tele) guidance in the form of repeated outpatient visits (physical visit, call and/or written form).  Since 2019, the outpatient clinic visit has been removed from the telemonitoring care activity, and telemedicine, thus, becomes a billable health product.

See full details in the Dutch here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more